Compare Roivant Sciences Ltd. Common Shares (ROIV) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.66 (market cap $2.27B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 10.9× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (6,279,442 versus 4,179,659). Which is the better fit depends on your goals.
| ROIV | SLS | |
|---|---|---|
Market Cap | $24.72B | $2.27B |
Volume | 6,279,442 | 4,179,659 |
Sector | Health | Health |
52-Week High | $41.81 | $15.46 |
52-Week Low | $16.04 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $20.99B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
